Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
“Four legs good, two legs bad.” – Snowball’s summary of the Seven Commandments of Animalism, Animal Farm Similar to Snowball’s cry, ‘NSAIDs bad, Opioids good’ has been the mantra chanted by nephrologists for many decades. How true
[read more...]Sodium/glucose cotransporter 2 inhibitors (SGLT2i / gliflozins) are a novel class of medications which act by inhibiting the SGLT2 transporter located in the S1 segment of the proximal convoluted tubule. This transporter is responsible for 90% of
[read more...]From 2015 to 2019, the United Network for Organ Sharing (UNOS) reported that only 18% of all kidney allografts were procured from living donors. Living donation is associated with better graft survival, less delayed graft function, and shorter
[read more...]Membranous nephropathy (MN) is the most common cause of primary nephrotic syndrome in adults of European ancestry. A better understanding of the pathophysiology has emerged in recent years identifying the PLA2R antigen and anti-PLA2R antibodies as
[read more...]Predicting progression is one of the most important and challenging jobs for a nephrologist. Current estimation in clinical practice is based on demographics, clinical parameters, and laboratory findings. About 15% of the adult population in the
[read more...]SARS-CoV2 is a virus that has shaken the scientific community to its core. As we struggle to catch up to a rapidly evolving global pandemic, it is of utmost importance that we understand and develop novel strategies to conserve the resources
[read more...]The COVID-19 pandemic presented unique challenges to both patients trying to obtain medical care and physicians providing the care. During this unprecedented time, telemedicine gave many patients a safe and convenient option to access medical
[read more...]That the arteriovenous fistula (AVF) is the lifeline for hemodialysis is a well-worn but well deserved cliché. The AVF has been a trusted vascular access for the last 55 years. Apart from allowing an individual on hemodialysis to swim and shower
[read more...]Chimeric antigen receptor T-cell (CAR-T) therapy is a type of treatment in which a patient’s T cells are changed in the laboratory so they will attack cancer cells. T cells are first taken from a patient’s blood. The gene for a special
[read more...]Introduction I used to think that if I studied physiology enough. If I developed a sophisticated model of how the body works, I could use it to recognize and respond to disease by choosing therapies that “made sense” to fix the patient. But a
[read more...]
